Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
Group Sign-on Letter to Congress (House) Opposing President’s Proposal to Eliminate Funding for HRSA’s Heritable Disorders Program
-
Group Sign-on Letter to Congress (Senate) Opposing President’s Proposal to Eliminate Funding for HRSA’s Heritable Disorders Program
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Comments to NIH about Development of the Genetic Test Registry